- Home
- ZKIN vs ATHA Comparison
ZKIN vs ATHA Comparison
Compare ZKIN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- ATHA
- Stock Information
- Founded
- ZKIN 2015
- ATHA 2011
- Country
- ZKIN China
- ATHA United States
- Employees
- ZKIN N/A
- ATHA N/A
- Industry
- ZKIN Metal Fabrications
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- ZKIN Industrials
- ATHA Health Care
- Exchange
- ZKIN Nasdaq
- ATHA Nasdaq
- Market Cap
- ZKIN 12.6M
- ATHA 10.6M
- IPO Year
- ZKIN 2017
- ATHA 2020
- Fundamental
- Price
- ZKIN $2.02
- ATHA $0.30
- Analyst Decision
- ZKIN
- ATHA Buy
- Analyst Count
- ZKIN 0
- ATHA 4
- Target Price
- ZKIN N/A
- ATHA $11.25
- AVG Volume (30 Days)
- ZKIN 27.9K
- ATHA 928.2K
- Earning Date
- ZKIN 01-27-2025
- ATHA 07-31-2025
- Dividend Yield
- ZKIN N/A
- ATHA N/A
- EPS Growth
- ZKIN N/A
- ATHA N/A
- EPS
- ZKIN N/A
- ATHA N/A
- Revenue
- ZKIN $108,199,877.00
- ATHA N/A
- Revenue This Year
- ZKIN N/A
- ATHA N/A
- Revenue Next Year
- ZKIN N/A
- ATHA N/A
- P/E Ratio
- ZKIN N/A
- ATHA N/A
- Revenue Growth
- ZKIN N/A
- ATHA N/A
- 52 Week Low
- ZKIN $0.82
- ATHA $0.22
- 52 Week High
- ZKIN $6.30
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- ZKIN 44.31
- ATHA 48.80
- Support Level
- ZKIN $1.90
- ATHA $0.29
- Resistance Level
- ZKIN $2.08
- ATHA $0.32
- Average True Range (ATR)
- ZKIN 0.14
- ATHA 0.02
- MACD
- ZKIN -0.04
- ATHA -0.00
- Stochastic Oscillator
- ZKIN 23.42
- ATHA 23.23
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.